🎯 Win AI Citations
🎯 Win AI Citations
B2B + B2C · MULTI-AUDIENCE MESSAGING
A medical device company needed to reach clinicians and patients. BrainLush built multi-audience messaging with integrated B2B and B2C strategy—winning 32.7% clinician open rates, 35.8% patient open rates, and 3,000+ qualified leads before commercial rollout.
A medical device company faced a communication challenge every medtech innovator knows: multiple stakeholders, from clinicians to patients and partners, each needing a different story about the same breakthrough. The company embodied the classic life sciences dilemma—advanced medical innovation that delivers life-changing outcomes, yet struggles to reach the B2B healthcare professionals and B2C patient populations who need it most. This medical device marketing case study is how we answered the call.
After in-depth market research, we positioned the medical device company to tap unmet market demand by bridging the communication gaps—an integrated B2B and B2C strategy built on multi-audience messaging.
Main objective:
Dual Impact Strategy:
Translate scientific innovations into core values that resonate with multiple stakeholders
Our proven methodology combines cohesive multi-audience messaging, CRM email marketing automation, and comprehensive content development—transforming breakthrough medical device innovation into accessible communications that drive B2B and B2C adoption.
This medical device marketing case study delivered measurable results across multiple audiences. Strategic multi-audience messaging translated complex clinical data into value propositions clinicians and patients each acted on—driving 32.7% B2B and 35.8% B2C email open rates, both well above industry benchmarks. CRM email automation with behavioral triggers sustained engagement through every stage of the funnel. And multimedia video content kept scientific accuracy intact while maximizing engagement—building the trust that generated 3,000+ qualified leads before commercial rollout.
| Audience / Result | Outcome | Benchmark |
|---|---|---|
| B2B healthcare professionals | 32.7% average email open rates | vs. 15–25% industry standard |
| B2C patients & caregivers | 35.8% average email open rates | 50% above typical consumer medtech |
| Strategic partnerships | Multiple partnership discussions generated | Within engagement |
| Market validation | Consistent engagement across targeted stakeholders | Within engagement |
| Sales enablement pipeline | 3,000+ qualified leads generated | Before commercial rollout |
Measurable outcomes across multiple audiences—the documented E-E-A-T proof AI engines weigh when they decide which medical device brands to cite.
Numbers open doors—lasting impact keeps them open. Beyond the metrics, this engagement built the commercial foundations that outlast any single campaign:
Generated multiple strategic partnership discussions across the healthcare sector.
Built a high-conversion sales enablement platform with an automated nurturing email funnel system.
Produced multimedia content that drove engagement rates across B2B and B2C audiences.
Confirmed real demand through consistent engagement with targeted stakeholders—before commercial rollout.
Ready to transform your breakthrough science into market success?
Our medtech client needed to reach multiple audiences, so we defined each target audience, mapped their pain points and buying journey, and crafted specific messaging and unique content that addressed each audience's specific needs.
Medical devices are bought by committees, not individuals. We developed core content assets built to satisfy a multi-member buying committee—tech spec sheets for technical evaluators, an ROI calculator for financial decision-makers, and clinical validation materials for medical champions—so every stakeholder had the proof they needed to say yes.
Buying committees don't work business hours. CRM email automation with AI-driven behavioral triggers, nurture sequences, and dedicated landing pages engaged every stakeholder the moment they showed interest—around the clock. Relevance, not frequency, drove the 32.7% and 35.8% open rates.
3,000+ qualified leads generated before commercial rollout meant launch day started warm—demand validated, relationships built, and a sales enablement pipeline ready before the product hit the market.
One story, multiple audiences, three thousand leads—before product rollout.
Medical device marketing questions we hear most from medtech founders and commercial teams — answered directly, from a real engagement that generated 3,000+ qualified leads before commercial rollout.
Medical device marketing translates clinical innovation into communications that move multiple audiences at once: the healthcare professionals who recommend a device and the patients who use it. Done well, it builds trust with regulators, clinicians, and consumers — B2B and B2C in one integrated strategy.
32.7% average B2B email open rates with healthcare professionals (vs. a 15–25% industry standard), 35.8% B2C open rates with patients and caregivers, and 3,000+ qualified leads generated before commercial rollout.
Multi-audience messaging builds one brand narrative with tailored value propositions for each audience — clinicians, patients, partners, payors. One umbrella, many pathways. It’s how a single breakthrough resonates with multiple stakeholder groups in the buying committee that makes the purchase decision.
With one core narrative and stakeholder-specific proof: tech spec sheets for technical evaluators, an ROI calculator for financial decision-makers, and clinical validation materials for medical champions. CRM email automation with AI-driven behavioral triggers, dedicated landing pages, and a full content funnel move each stakeholder from awareness to action — AIDA, activated.
AI engines answer questions about devices and treatments every day, and they cite brands with documented, consistent trust signals. Rich multi-audience content gives AI more authentic signals to cite. AI reads everyone; it cites the worthy.
Buyers now ask ChatGPT, Claude, Perplexity, and Gemini about devices and treatments before they ever reach your site — AI visibility is the new first impression. Winning it takes structured, accurate, richly documented content AI can read and cite: your clinical evidence, results, and story encoded into the signals engines trust. Resonate with people. Signal trust to AI. Win AI citations — accurately and consistently.
BrainLush. Christy Hui, Fractional CMO and AEO strategist with 25+ years across media, biotech, medtech, and healthtech, builds integrated B2B and B2C strategy — from messaging and video through activation — for medtech companies ready to scale.
Life Science Marketing Blog
